当前位置: 首页 >> 检索结果
21. Impact of treatments on fatigue in axial spondyloarthritis: a systematic review and meta-analysis.
作者: Clémentine Delcourt.;Olivier Fakih.;Clément Prati.;Mickaël Chouk.;Daniel Wendling.;Frank Verhoeven.
来源: Rheumatology (Oxford). 2025年64卷4期1585-1597页
Fatigue is frequent in axial SpA (axSpA) and is difficult to improve. This systematic review aimed to assess the effects of axSpA treatment on fatigue.
22. Menopausal state and rheumatoid arthritis: a systematic review and meta-analysis.
作者: Negin Namavari.;Mohammad Jokar.;Arnoosh Ghodsian.;Hossein Kargar Jahromi.;Vahid Rahmanian.
来源: BMC Rheumatol. 2024年8卷1期48页
Rheumatoid arthritis (RA) is a chronic inflammatory condition primarily affecting the joints. The higher prevalence of RA among females, combined with the known effects of sex hormones on immune function, has led researchers to investigate the potential relationship between menopausal status and the risk, severity, or progression of RA. This systematic review and meta-analysis aimed to determine the association between menopause and rheumatoid arthritis.
23. Crystal-induced arthritis in prosthetic joints: a systematic review of clinical features, diagnosis, management, and outcomes.
作者: Haruki Sawada.;Jared Dang.;Bibek Saha.;Luke Taylor.;Yoshito Nishimura.;Melissa Kahili-Heede.;Cass Nakasone.;Sian Yik Lim.
来源: BMC Rheumatol. 2024年8卷1期43页
To summarize clinical presentations, baseline characteristics, diagnosis, treatment, and treatment outcomes through a systematic review of cases of crystal-induced arthritis in prosthetic joints in the literature.
24. Imaging findings in cardiovascular involvements of IgG4-related disease: a systematic review study.
作者: Amir Ghaffari Jolfayi.;Alireza Salmanipour.;Kiyan Heshmat-Ghahdarijani.;Shahla Meshgi.;Maedeh Dastmardi.;Ghazaleh Salehabadi.;Amir Azimi.;Mohammad Hossein Mozafary Bazargany.;Peyvand Parhizkar Roudsari.;Behnaz Mahmoodiyeh.;Ali Mohammadzadeh.
来源: Rheumatology (Oxford). 2025年64卷3期943-951页
Immunoglobulin G4-related disease (IgG4-RD) is a fibroinflammatory condition characterized by IgG4-positive plasma cell infiltration that can affect multiple organs, including the cardiovascular system. The diagnosis of IgG4-RD relies on a combination of clinical, serological, radiological and pathological findings. However, due to the varied and insidious clinical presentations, normal IgG4 levels in a significant percentage of patients and frequent multi-organ involvement, imaging plays a crucial role in the diagnosis of IgG4-RD. The aim of this study is to comprehensively examine the imaging findings in IgG4-related cardiovascular disease for accurate diagnosis and appropriate treatment.
25. Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis.
作者: Merlijn Wind.;Juan J Fierro.;Kitty W M Bloemenkamp.;Karina de Leeuw.;A Titia Lely.;Maarten Limper.;Marieke Sueters.;Y K Onno Teng.;Isabel J Walter.;Judith Kooiman.
来源: Lancet Rheumatol. 2024年6卷10期e667-e683页
To enhance patient-tailored preconception risk assessment for women with systemic lupus erythematosus (SLE), knowledge on risk factors associated with adverse pregnancy outcomes is required. Therefore, we did a systematic review and meta-analysis to identify and provide unambiguous effect sizes of preconception predictors of pregnancy outcomes in women with SLE.
26. Definitions of and instruments for disease activity, remission and relapse in polymyalgia rheumatica: a systematic literature review.
作者: Thomas E Bolhuis.;Philipp Bosch.;Louise Falzon.;Claire E Owen.;Max Yates.;Sarah L Mackie.;Aatke van der Maas.;Christian Dejaco.
来源: Rheumatology (Oxford). 2025年64卷2期455-469页
To perform a systematic literature review on definitions and instruments used to measure remission, relapse and disease activity in polymyalgia rheumatica (PMR), to inform an OMERACT project to endorse instruments for these outcomes.
28. Validation of HAND OA US inflammatory and structural damage score (HOUSE) for thumb-base joints: systematic review on truth and discrimination.
作者: Marion C Kortekaas.;Tine Vanhaverbeke.;Helen I Keen.;Lene Terslev.;Hilde B Hammer.;Maria Antonietta D'Agostino.;Ruth Wittoek.; .
来源: Rheumatology (Oxford). 2025年64卷3期919-934页
Recently, the HAND OA US Examination (HOUSE) inflammatory and structural damage scores were developed by the OMERACT US Working Group. However, the thumb base was not, or was only partly, included. This systematic review examines US scoring methods and scanning techniques assessing thumb-base OA, alongside existing evidence on validity, reliability and responsiveness.
29. Management and outcomes of interstitial lung disease associated with anti-synthetase syndrome: a systematic literature review.
作者: Koushan Kouranloo.;Mrinalini Dey.;Helen Elwell.;Veronica Yioe.;Lisa G Spencer.;Caroline V Cotton.
来源: Rheumatology (Oxford). 2025年64卷1期45-55页
Anti-synthetase syndrome (ASS) is a chronic autoimmune condition, with interstitial lung disease (ILD) being a key feature. This systematic literature review (SLR; CRD42023416414) aimed to summarize treatments and outcomes of ILD associated with ASS (ASS-ILD).
30. Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project.
作者: Francesco Baldo.;Remco G A Erkens.;Mao Mizuta.;Greta Rogani.;Federica Lucioni.;Claudia Bracaglia.;Dirk Foell.;Marco Gattorno.;Marija Jelusic.;Jordi Anton.;Paul Brogan.;Scott Canna.;Shanmuganathan Chandrakasan.;Randy Q Cron.;Fabrizio De Benedetti.;Alexei Grom.;Merav Heshin-Bekenstein.;AnnaCarin Horne.;Raju Khubchandani.;Seza Ozen.;Pierre Quartier.;Angelo Ravelli.;Masaki Shimizu.;Grant Schulert.;Christiaan Scott.;Rashmi Sinha.;Nicolino Ruperto.;Joost F Swart.;Sebastiaan Vastert.;Francesca Minoia.; .
来源: Rheumatology (Oxford). 2025年64卷1期32-44页
To assess current treatment in macrophage activation syndrome (MAS) worldwide and to highlight any areas of major heterogeneity of practice.
31. Could tocilizumab be used in familial Mediterranean fever? A systematic review.
作者: Philippe Mertz.;Véronique Hentgen.;Sophie Georgin-Lavialle.
来源: Rheumatology (Oxford). 2025年64卷1期12-21页
Familial Mediterranean Fever (FMF) is the most common monogenic autoinflammatory disease characterized by recurrent fever and serosal inflammation. Although colchicine is the primary treatment, around 10% of FMF patients do not respond to it, necessitating alternative therapies. Biologic treatments, such as IL-1β, TNF-α and IL-6 inhibitors, have been considered. However, the accessibility and cost of IL-1β inhibitors may limit their use in certain regions. Tocilizumab (TCZ), an IL-6 receptor inhibitor, offers an alternative, but its efficacy in FMF is not well-documented.
32. Association of ankylosing spondylitis with the risk of cancer: a meta-analysis of cohort studies.
作者: Lulin Yu.;Yici Yan.;Wenjing Liu.;Siyu Huang.;Leitao Sun.;Shanming Ruan.
来源: Rheumatology (Oxford). 2025年64卷2期440-454页
The potential impact of ankylosing spondylitis (AS) on cancer risk remains unclear. This study seeks to investigate the relationship between AS and different types of cancers.
33. Efficacy and safety of biologic drugs in Still's disease: a systematic review and network meta-analysis of randomized controlled trials.
作者: Berkay Kilic.;Admir Ozturk.;Sejla Karup.;Ervanur Hacioglu.;Serdal Ugurlu.
来源: Rheumatology (Oxford). 2025年64卷1期22-31页
Still's disease is a rare autoinflammatory disorder characterized by systemic inflammation, fever, rash and arthritis. The term 'Still's disease' covers the paediatric subtype systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD), which affects adults. Biologic drugs, including the anti-IL-1 agents anakinra, canakinumab and rilonacept and the IL-6 antagonist tocilizumab, are used in the management of Still's disease.
34. Mental health conditions in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
作者: Xiaotong Liu.;Xinlei Jia.;Xiao Wang.;Ya Bin Wei.;Jia Jia Liu.
来源: Rheumatology (Oxford). 2024年63卷12期3234-3242页
The reported prevalence of mental health conditions (MHCs) in people with systemic lupus erythematosus (SLE) ranges widely. Whether MHCs are associated with increased risk of SLE or the outcomes of the disease is unclear. This study aimed to conduct an umbrella and updated meta-analysis of MHCs in people with SLE and to identify whether MHCs are associated with the risk of SLE or patient outcomes.
35. Risk of diabetes mellitus in systemic lupus erythematosus: systematic review and meta-analysis.
作者: Ivet Etchegaray-Morales.;Claudia Mendoza-Pinto.;Pamela Munguía-Realpozo.;Juan Carlos Solis-Poblano.;Socorro Méndez-Martínez.;Jorge Ayón-Aguilar.;Carlos Abud-Mendoza.;Mario García-Carrasco.;Ricard Cervera.
来源: Rheumatology (Oxford). 2024年63卷8期2047-2055页
To investigate the risk of DM and evaluate the impact of SLE therapies on the risk of developing DM in patients with SLE.
36. Pharmacological interventions for early-stage frozen shoulder: a systematic review and network meta-analysis.
作者: Juan Enrique Berner.;Marios Nicolaides.;Stephen Ali.;Georgios Pafitanis.;Jane Preece.;Sally Hopewell.;Jagdeep Nanchahal.
来源: Rheumatology (Oxford). 2024年63卷12期3221-3233页
To evaluate the efficacy of pharmacological interventions for treating early-stage, pain predominant, adhesive capsulitis, also known as frozen shoulder.
37. The worldwide prevalence of psoriatic arthritis-a systematic review and meta-analysis.
作者: Stephanie Lembke.;Gary J Macfarlane.;Gareth T Jones.
来源: Rheumatology (Oxford). 2024年63卷12期3211-3220页
Previous attempts to pool prevalence studies in PsA have failed to take account of important methodological differences between studies that may have created biased estimates. The aim of this review is to estimate the prevalence of PsA within the adult general population worldwide, considering potential differences between population-based and health administrative studies separately.
38. Risk of cardiovascular disease decreases over time in psoriatic arthritis but not in spondylarthritis: meta-analysis of longitudinal studies.
作者: Hélène Gouze.;Philippe Aegerter.;Yasmine Gouyette.;Maxime Breban.;Maria Antonietta D'Agostino.
来源: Rheumatology (Oxford). 2024年63卷10期2638-2647页
SpA and PsA represent two frequent inflammatory rheumatic disorders characterized by an increased burden on quality of life due to the association of several comorbidities, especially cardiovascular disease (CVD). The estimated prevalence of CVD ranges from 12 to 19% and differs between the two diseases, however, the incidence of CVD is not completely known. We aimed to systematically review the literature and perform a meta-analysis of controlled observational studies to assess the incidence rate of CVD over time in SpA and PsA.
39. The information required by people with inflammatory arthritis when taking Methotrexate: a mixed-methods systematic review.
作者: Sarah J Logan.;Samantha Hider.;Julie Green.;Sarah J Ryan.
来源: Rheumatology (Oxford). 2024年63卷10期2615-2623页
This mixed-methods systematic review aimed to identify and synthesize knowledge of the characteristics, content, and preferred format of information to support people with inflammatory arthritis (IA) to take MTX.
40. Effect of gender and age on bDMARD efficacy for axial spondyloarthritis patients: a meta-analysis of randomized controlled trials.
To study the therapeutic variations of biologic and targeted synthetic DMARDs (b/tsDMARDs) between genders and across age stages in axial SpA (axSpA) patients through meta-analysis.
|